Journal of Medical Economics
Volume 24, 2021 - Issue 1
Open access
1,795
Views
3
CrossRef citations to date
0
Altmetric
Neurology
The implications of suboptimal year-1 outcomes with disease-modifying therapy in employees with multiple sclerosis
Carrie M. Hersha Cleveland Clinic, Lou Ruvo Center for Brain Health, Las Vegas, NV, USACorrespondence[email protected]
, Richard A. Brookb President, Better Health Worldwide, Inc., Newfoundland, NJ, USA
, Ian A. Berenc Integrated Analytics Department, Workpartners LLC, Cheyenne, WY, USA
, Nicholas J. Rohrbackerc Integrated Analytics Department, Workpartners LLC, Cheyenne, WY, USA
, Lori Lebsond Neurology and Immunology, EMD Serono, Inc., One Technology Place, Rockland, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany
, Christian Henkee Global Evidence & Value Development, Merck KGaA, Darmstadt, Germany
& Amy L. Phillipsf Health Economics and Outcomes Research, EMD Serono, Inc., One Technology Place, Rockland, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany
show all
Pages 479-486
|
Received 11 Jan 2021, Accepted 08 Mar 2021, Published online: 13 Apr 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.